The use of flavoxate in cystitis and renal colic

References

• Ali, C., (1968). Controlled clinical trial of a new combination with a myolytic-analgesic action in urology. Min. urol., 20, 280–288.1. Ali, C., (1968). Controlled clinical trial of a new combination with a myolytic-analgesic action in urology. Min. urol., 20, 280–288.
   Google Scholar
• Arduini, M., and Natili, G., (1969). Cystometric evaluation of the decontracturant action of a new synthetic antispasmodic drug (flavoxate) in neurogenic bladders. Min. urol., 21, 127–131.2. Arduini, M., and Natili, g., (1969). Cystometric evaluation of the decontracturant action of a new synthetic antispasmodic drug (flavoxate) in neurogenic bladders. Min. urol., 21, 127–131.
   PubMedGoogle Scholar
• Bradley, D. V., and Cazort, R. J., (1970). Relief of bladder spasm by flavoxate; a comparative study. J. clin. Pharm., 10, 65.3. Bradley, D. V., and Cazort, R. J., (1970). Relief of bladder spasm by flavoxate; a comparative study. J. clin. Pharm., 10, 65.
   Web of Science ®Google Scholar
• Capra, A., and Paggi, G., (1972). Use of flavoxate in the treatment of threatened abortion and threatened premature birth. Min. ginec., 24, 400.4. Capra, A., and Paggi, g., (1972). Use of flavoxate in the treatment of threatened abortion and threatened premature birth. Min. ginec., 24, 400.
   PubMedGoogle Scholar
• Da-Costa-Regua, O. Jnr., (1968). Use of flavoxate (Rec. 7/0040) in urology. O. Hasp., 73, 1659.5. Da-Costa-Regua, O. Jnr., (1968). Use of flavoxate (Rec. 7/0040) in urology. O. Hasp., 73, 1659.
   PubMedGoogle Scholar
• Da Re, P., Verticchi, L., and Setnikar, I., (1960). Some basic derivatives of 3-methylflavone-8-carboxylic acid. J. med. Pharm. Chem., 2, 263.6. Da Re, P., Verticchi, L., and Setnikar, I., (1960). Some basic derivatives of 3-methylflavone-8-carboxylic acid. J. med. Pharm. Chem., 2, 263.
   PubMedGoogle Scholar
• Esposito, A., (1959). The action of some synthetic preparations similar to paperavine on the contractions of the human uterus “in vitro”. Proc. Ital. Soc. Ob. Gyn., 47, 1645–1651.7. Esposito, A., (1959). The action of some synthetic preparations similar to paperavine on the contractions of the human uterus “in vitro”. Proc. Ital. Soc. Ob. Gyn., 47, 1645–1651.
   Google Scholar
• Herbst, W. P., (1970). Double-blind comparison of flavoxate and propantheline as urologic antispasmodics. Amer. J. clin. Res., 1, 65.8. Herbst, W. P., (1970). Double-blind comparison of flavoxate and propantheline as urologic antispasmodics. Amer. J. clin. Res., 1, 65.
   Google Scholar
• Kohler, F. P., and Morales, P. A., (1968). Cystometric evaluation of flavoxate hydrochloride in normal and neurogenic bladders. J. Urol., 100, 729.9. Kohler, F. P., and Morales, P. A., (1968). Cystometric evaluation of flavoxate hydrochloride in normal and neurogenic bladders. J. Urol., 100, 729.
   PubMed Web of Science ®Google Scholar
• Pagano, F., (1966). Remarks on the use in urology of a synthetic spasmolytic with myotropic action. Urologica, 33, Suppl. 19, 101–106.10. Pagano, F., (1966). Remarks on the use in urology of a synthetic spasmolytic with myotropic action. Urologica, 33, Suppl. 19, 101–106.
   Google Scholar
• Pedersen, E., Bjarnason, E. V., and Hansen, P. H., (1972). The effect of flavoxate on neurogenic bladder dysfunction. Acta neural. Scand., 48, Supp. 51, 487.11. Pedersen, E., Bjarnason, E. V., and Hansen, P. H., (1972). The effect of flavoxate on neurogenic bladder dysfunction. Acta neural. Scand., 48, Supp. 51, 487.
   Google Scholar
• Raffaelli, F., and Romano, F., (1968). Clinical trial of the combination flavoxate-metamizole in obstetrics and gynaecology. Arch. Sic. Med. Chir., 9, 3–16.12. Raffaelli, F., and Romano, F., (1968). Clinical trial of the combination flavoxate-metamizole in obstetrics and gynaecology. Arch. Sic. Med. Chir., 9, 3–16.
   Google Scholar
• Resti, M., and Concoreggi, E., (1966). Clinical trial of a new synthetic spasmolytic. Riv. Patol. Clin., 21, 201–208.13. Resti, M., and Concoreggi, E., (1966). Clinical trial of a new synthetic spasmolytic. Riv. Patol. Clin., 21, 201–208.
   Google Scholar
• Saporiti, E., and Viggiano, G., (1968). Clinical experiences with a new spasmolytic-analgesic combination in renal colic. Min. urol., 20, 273.14. Saporiti, E., and Viggiano, g., (1968). Clinical experiences with a new spasmolytic-analgesic combination in renal colic. Min. urol., 20, 273.
   Google Scholar
• Setnikar, I., (1960). Pharmacological study of a new synthesised antispasmodic. Rev. Bras. Med., 17, 407–409.15. Setnikar, I., (1960). Pharmacological study of a new synthesised antispasmodic. Rev. Bras. Med., 17, 407–409.
   PubMedGoogle Scholar
• Setnikar, I., Ravasi, M. T., and Da Re, P., (1960). Pharmacological properties of piperidino-ethyl-3-methylflavone-8-carboxylate hydrochloride, a smooth muscle relaxant. J. Pharm. exp. Therap., 130, 356–363.16. Setnikar, I., Ravasi, M. T., and Da Re, P., (1960). Pharmacological properties of piperidino-ethyl-3-methylflavone-8-carboxylate hydrochloride, a smooth muscle relaxant. J. Pharm. exp. Therap., 130, 356–363.
   PubMed Web of Science ®Google Scholar
• Sorrentino, F., (1967). The use of a new synthetic spasmolytic in ecbolic therapy of ureteral calculosis. Min. urol., 19, 209–211.17. Sorrentino, F., (1967). The use of a new synthetic spasmolytic in ecbolic therapy of ureteral calculosis. Min. urol., 19, 209–211.
   PubMedGoogle Scholar
• Zaffiri, O., Menesini, R., and Gorgerino, F., (1965). The treatment of spastic painful conditions in prostatectomized patients with a new synthetic spasmolytic. Min. anest., 31, 512–514.18. Zaffiri, O., Menesini, R., and Gorgerino, F., (1965). The treatment of spastic painful conditions in prostatectomized patients with a new synthetic spasmolytic. Min. anest., 31, 512–514.
   Google Scholar
• Zanollo, A., and Cavaciuti, P., (1965). Treatment of painful spastic conditions of the urinary tract with a new synthetic myolytic drug. Min. urol., 17, 115–121.19. Zanollo, A., and Cavaciuti, P., (1965). Treatment of painful spastic conditions of the urinary tract with a new synthetic myolytic drug. Min. urol., 17, 115–121.
   PubMedGoogle Scholar